The putative role of JARID1B as an oncogene in cancer development is supported by the observations that JARID1B is highly expressed in prostate cancer and other malignant tumors relative to normal tissues [12, 23, 32, 13]. This evidence concerns the gene KDM5B and prostate cancer.